SUPPLY OF MEDICINES AS PER ATTACHED BOQ 112709756

The Directorate of Purchase and Stores has published a tender for "SUPPLY OF MEDICINES AS PER ATTACHED BOQ" on the 23 Dec 2024. This tender belongs to Insulin category. This tender is published in Mumbai, Maharashtra location. The vendors interested in this tender and related Insulin tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
Related alert: pharmacy medicines Tenders | human insulin Tenders | allopathic medicine Tenders
Related categories: Acarbose Tenders | Glimepiride Tenders | Glipizide Tenders |

Did You Know?

Maharashtra has published 255 tenders in Insulin in the last financial year.

Out of these, 14 were published last month.

🚀 Unlock Latest Indian Government Tenders — Free Updated daily with verified government procurement notices.
Tender Details
 Tender Title / Description
Tender Title SUPPLY OF MEDICINES AS PER ATTACHED BOQ
Tender Description injection,mixture of insulin aspart & protamine crystallised insulin aspart (biosynthetic r-dna origin) each ml suspension contains 100 u (3.5mg) of insulin aspart (r-dna origin), (30% as soluble insulin aspart & 70% as insulin aspart protamine crystals), phenol 1.5mg and metacresol 1.72mg (as presvatives) excipients q.s. 100 u/ml in 3.0ml cartridges (pack of 5 cartridges with compatible pen) injection,infliximab,100 mg insulin lispro (100 u/ml) containing insulin lispro 1.39 mg, clycerol 16 mg, zinc oxide q. s., dibasic sodium phosphate 1.88%, m-cresol 3.15 mg, water for injection q.s./ml (against each 25 cartridges one compatible pen shall be provided) l-ornithine l-asparte infusion, 10ml contains l-orinthine l-asartate 5g, water for injection q.s injection, levetiracetam, 500mg in 5ml vial inj liraglutide 6 mg / ml injection,metoclopramide,2ml/amp injection,noradrenaline bitartrate,4mg/2ml injection,ofloxacin 200mg,100ml/bottle injection,pheniramine maleate 22.75mg/ml,2ml/amp injec
Comments injection,mixture of insulin aspart & protamine crystallised insulin aspart (biosynthetic r-dna origin) each ml suspension contains 100 u (3.5mg) of insulin aspart (r-dna origin), (30% as soluble insulin aspart & 70% as insulin aspart protamine crystals), phenol 1.5mg and metacresol 1.72mg (as presvatives) excipients q.s. 100 u/ml in 3.0ml cartridges (pack of 5 cartridges with compatible pen) injection,infliximab,100 mg insulin lispro (100 u/ml) containing insulin lispro 1.39 mg, clycerol 16 mg, zinc oxide q. s., dibasic sodium phosphate 1.88%, m-cresol 3.15 mg, water for injection q.s./ml (against each 25 cartridges one compatible pen shall be provided) l-ornithine l-asparte infusion, 10ml contains l-orinthine l-asartate 5g, water for injection q.s injection, levetiracetam, 500mg in 5ml vial inj liraglutide 6 mg / ml injection,metoclopramide,2ml/amp injection,noradrenaline bitartrate,4mg/2ml injection,ofloxacin 200mg,100ml/bottle injection,pheniramine maleate 22.75mg/ml,2ml/amp injec
 Important Dates
Published Date
Due Date 15 Jan 2025 00:00:00
 Estimate and EMD
Estimated Value 0.0
EMD 0 INR
Processing Fee 0 INR
 Document Links
 Purchasing Agency
 Tender No

TSID: 112709756

 Tender Type and Location
Tender Category
Tender Type
WhatsApp Chat